Duke Ophthalmology Ranks 10th Nationally in NIH Funding
Duke School of Medicine has received more than $527 million in federal funding from the National Institute of Health (NIH) in 2022, ranking ninth nationally, according to the Blue Ridge Institute f
Duke Eye Center Faculty at Hawaiian Eye and Retina 2023
Duke Eye Center faculty were among the presenters at the annual Hawaiian Eye and Retina meeting held January 14-20, 2023. This meeting features world-class educators, practi
Duke is the Lead Site for Atmosphere and Ascent Trials
Duke Eye Center is participating in two pivotal gene therapy clinical trials, ATMOSPHERE and ASCENT that may become promising treatments for age-related macular degeneration. The studies
Welcome Residency Class of 2027!
We are pleased to announce the Duke Eye Center Residency Class of 2027! A talented group of individuals who have chosen to be part of the next generation of ophthalmologists. We look fo
Alekseev Receives 2023 Strong Start Award
Oleg Alekseev, MD, PhD, is one of four School of Medicine faculty members have be
Hsu Receives Education Grant to Present at Retina Society
S. Tammy Hsu, MD, PGY4 received the Jack McGovern Coats' Disease Foundation 2022 Education Grant.
Kuo Receives Prestigious Physician-Scientist Award
Anthony Kuo, MD, was granted a $300,000 RPB Physician-Scientist Award to support his project "Robotically Assisted Anterior E
WIO Board of Directors
Two members of Duke Eye Faculty have been elected to serve on the 2023 Women in Ophthalmology Board of Directors.
Video Series: Emerging Treatment Options for Geographic Atrophy
HCPLive in collaboration with expert retina specialists including moderator Eleonora Lad, MD, PhD, associate professor of ophthalmology, launched an educational video series, "Emerging Treatment Op
Research Shows Expanded Use of PRGF Drops Effective
Plasma Rich Growth Factors (PRGF) blood-derived eye drops have been used for some time to treat severe ocular surface disease. New research now shows PRGF to be a safe, effective, and well-to